Voyageur Pharmaceuticals (CVE:VM) Trading Down 31.3% – Here’s What Happened

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) dropped 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during mid-day trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The stock’s fifty day moving average price is C$0.10 and its 200 day moving average price is C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market cap of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.